I am interested in understanding age differences across the lifespan in cognitive and attentional control.
To explore age-specific challenges in these cognitive functions during response conflicts and decision making, I make use of (neuro)physiological measures that allow to inform age differences in behavioral measures. These include EEG, fMRI and pupillometry.
A current focus lies on understanding how the noradrenergic system is changing in healthy ageing and dementia. These are still early days of understanding how noradrenaline influences cognitive functions, but recent studies show its invovlement in emotional memory and attentional control (see also selected publications). In Alzheimer's Disease, the noradrenergic system is one of the first to show brain lesions. Improving its structural and functional assessment will help detecting AD earlier and working towards stopping its progression.